STK33 and hepatocellular carcinoma: Furthermore, STK33 is overexpressed in hypopharyngeal squamous cell carcinoma [15], hepatocellular carcinoma [16], human large cell lung cancer [17], and pancreatic cancer [18] and the increased expression of STK33 may subsequently promote tumorigenesis and disease progression.